Pacific Biosciences Of California (PACB) Change in Inventory (2011 - 2026)

Pacific Biosciences Of California's Change in Inventory history runs 16 years deep, the most recent figure standing at $3.2 million for Q1 2026.

• In Q1 2026, Change in Inventory rose 26.32% year-over-year to $3.2 million; the TTM figure through Mar 2026 stood at $2.1 million (up 361.86% YoY), while the FY2025 annual figure was $1.4 million, down 82.94% from the prior year.
• Change in Inventory was $3.2 million for Q1 2026 at Pacific Biosciences Of California, up from -$3.5 million in the prior quarter.
• In the past five years, Change in Inventory ranged from a high of $13.3 million in Q1 2023 to a low of -$9.0 million in Q4 2023.
• Historically, Change in Inventory has averaged $3.6 million across 5 years, with a median of $3.2 million in 2026.
• The sharpest annual moves came in 2022 and 2023: Change in Inventory jumped 235.25% in 2022, then plunged 185.47% in 2023.
• A 5-year view of Change in Inventory shows it stood at $10.5 million in 2022, then slumped by 185.47% to -$9.0 million in 2023, then increased by 21.47% to -$7.1 million in 2024, then surged by 50.42% to -$3.5 million in 2025, then jumped by 191.42% to $3.2 million in 2026.
• The last three Change in Inventory figures came in at $3.2 million (Q1 2026), -$3.5 million (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.